Jacobs Levy Equity Management’s St Jude Medical STJ Stock Holding History

Jacobs Levy Equity Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-116,300	Closed	-$6.4M	–	1295
2016 Q1	$6.4M	Buy	116,300 +4,300	+4%	+$234K	0.14%	195
2015 Q4	$6.92M	Buy	112,000 +16,140	+17%	+$1.02M	0.14%	187
2015 Q3	$6.05M	Buy	95,860 +51,750	+117%	+$3.69M	0.12%	196
2015 Q2	$3.22M	Sell	44,110 -10,700	-20%	-$773K	0.06%	291
2015 Q1	$3.58M	Buy	54,810 +48,000	+705%	+$3.19M	0.06%	281
2014 Q4	$443K	Sell	6,810 -466,920	-99%	-$30.1M	0.01%	623
2014 Q3	$28.5M	Sell	473,730 -24,800	-5%	-$1.62M	0.48%	54
2014 Q2	$34.5M	Sell	498,530 -31,460	-6%	-$2.04M	0.57%	34
2014 Q1	$34.7M	Buy	529,990 +24,260	+5%	+$1.58M	0.58%	38
2013 Q4	$31.3M	Sell	505,730 -60,640	-11%	-$3.51M	0.47%	60
2013 Q3	$30.4M	Sell	566,370 -66,670	-11%	-$3.43M	0.51%	45
2013 Q2	$28.9M	Buy	+633,040	New	+$27.4M	0.51%	44

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jacobs Levy Equity Management's STJ Position: Q2 2016 in Review

Jacobs Levy Equity Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 116,300 shares — an estimated $6.4M sold.

Jacobs Levy Equity Management first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $34.7M in Q1 2014. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Jacobs Levy Equity Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Jacobs Levy Equity Management sold 116,300 St Jude Medical shares in Q2 2016, an estimated $6.4M.
Jacobs Levy Equity Management first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
Jacobs Levy Equity Management's St Jude Medical position peaked at $34.7M in Q1 2014.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.